Date: Fri, 29 Mar 2024 06:56:17 +0100 (CET) Message-ID: <1904506601.25875.1711691777172@[192.168.128.197]> Subject: Exported From Confluence MIME-Version: 1.0 Content-Type: multipart/related; boundary="----=_Part_25874_523909316.1711691777171" ------=_Part_25874_523909316.1711691777171 Content-Type: text/html; charset=UTF-8 Content-Transfer-Encoding: quoted-printable Content-Location: file:///C:/exported.html
You are here:
Answer:
This question is addressed in the General Notices. The test(s) = that constitute the first identification may be used in all circumstances. = The test(s) that constitute the second identification may be used in pharma= cies only, provided it can be demonstrated that the substance, preparation = or medicinal product is fully traceable to a batch certified to comply with= all the other requirements of the monograph.